Showing 31-40 of 245 results for "".
Improving Outcomes with Neuromodulators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-outcomes-with-neuromodulators/18521/Joel L. Cohen, MD offers treatment tips for best, natural outcomes with neuromodulator injections. He also discusses how injecting toxins prior to resurfacing or prior to filler injections can improve results and duration of effects.PDT in Action: New Options for Actinic Keratosis
https://practicaldermatology.com/series/pdt-in-practice/pdt-in-action-new-options-for-actinic-keratosis/20210/Dr. Joel L. Cohen, a board-certified dermatologist practicing in Denver, shares insights into the use of photodynamic therapy (PDT) in his practice and how PDT has impacted the options for the treatment of actinic keratosis.Skin Cancer Prevention: Can Laser Therapy Help?
https://practicaldermatology.com/conferences/scale-2023/skin-cancer-prevention-can-laser-therapy-help/20205/Non-ablative fractional laser treatments may dramatically the reduce risk of skin cancer recurrence. Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss the science behind this intriguing finding.Scientifically Speaking: Advances in Microneedling
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-advances-in-microneedling/20012/Anna Guanche, MD; Mara Weinstein Velez, MD; and Doris Day, MD discuss PRP, RF micondeeling, and other advances in patient care with host Joel L. Cohen, MD.Scientifically Speaking: Nanopulse Stimulation with Darrin Uecker
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-nanopulse-stimulation-with-darrin-uecker/20111/The CellFX system from Pulse Biosciences is a true platform technology, says President/CEO Darrin Uecker. He talks to host Joel L. Cohen, MD about the technology, its application, and potential future uses.First, Do No Harm
https://practicaldermatology.com/conferences/scale-2023/first-do-no-harm/20206/Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss why dermatologists should report any side effects to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database.Noah Worcester 2024: Dr. Jogi on Hair Loss
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-jogi-hair-loss/24590/Joel L. Cohen, MD, FAAD, interviews Reena Jogi, MD about her lecture on hair loss and platelet-rich plasma at the 2024 Noah Worcester Dermatological Society meeting.Fractional Lasers for NMSC and More
https://practicaldermatology.com/conferences/scale-2025/fractional-lasers-for-nmsc-and-more/35876/Joel L. Cohen, MD, FAAD, and Matthew M. Avram, MD, talk about research involving fractional lasers, including as part of combination treatments for nonmelanoma skin cancer, at Music City SCALE 2025.Therapeutic Advances and Fighting for Authorizations
https://practicaldermatology.com/programs/practical-dermatology/therapeutic-advances-and-fighting-for-authorizations/35890/Joel L. Cohen, MD, FAAD, and Leon Kircik, MD, FAAD, discuss the latest developments in psoriasis and atopic dermatitis, as well as the challenges involved with fighting for prior authorizations for the best therapies, at Music City SCALE 2025.Rosacea Treatment Options and Strategies
https://practicaldermatology.com/programs/practical-dermatology/rosacea-treatment-options-and-strategies/35893/Joel L. Cohen, MD, FAAD, and Hilary Baldwin, MD, talk at Music City SCALE 2025 about the latest treatment options for rosacea and strategies for getting patient buy-in.